Johnson on Gastroenterology

 
 
  • Going Gluten-Free: Value Beyond Celiac Disease?   Increasing numbers of individuals without celiac disease report relief of GI symptoms with a gluten-free diet. What's the evidence behind it? Dr. David Johnson offers commentary and clinical guidance.
  • A ‘Killer’ of a Reason to Treat Hepatitis C   Dr. David Johnson stresses the importance of treating patients with hepatitis C and advanced hepatic fibrosis, given that those with sustained treatment response have a lower all-cause mortality rate.
  • Endoscopy Screening for GERD: Best Practices   Dr. David Johnson discusses new guidelines from the American College of Physicians for upper endoscopy for GERD. What’s the clinical evidence behind them, and how will they affect practice?
  • What Happens in Vegas: Highlights From ACG 2012   Dr. David Johnson shares some of the key data from this year’s American College of Gastroenterology meeting that really shouldn't stay in Vegas
  • Eosinophilic Esophagitis: What Is Appropriate Therapy?   Results from 2 recent studies on corticosteroids for eosinophilic esophagitis raise questions about the appropriate initial therapy for patients. Dr. David Johnson offers his perspective.
  • Could We Be Missing Skin Cancer in IBD Patients? Dr. David Johnson offers commentary on the evolving data regarding the risk of melanoma and nonmelanoma skin cancer in patients with inflammatory bowel disease, and how medication may play a role.
  • Endoscopy in Pregnancy: Risks and Safety   New guidelines aim to minimize the risk to the unborn child when endoscopy can't be postponed until after birth.
  • Diagnosis and Management of NAFLD: New Guidelines   Dr. David Johnson discusses the newly published guidelines for diagnosing and managing nonalcoholic fatty liver disease. What’s the clinical evidence behind them, and how will they affect practice?
  • Fecal Transplantation for C difficile: An Evolving 'Art'   Dr. David Johnson discusses the therapeutic option of fecal transplantation for recurrent Clostridium difficile infection. How is it done, and is it effective?
  • Asking the Right Questions, Choosing the Right Tests   As part of the Choosing Wisely campaign, the American Gastroenterological Association created a list: "Five Things Physicians and Patients Should Question." Dr. David Johnson offers commentary.
  • Fluoroquinolones and Retinal Detachment: See No Evil?   A recent study suggests that retinal detachment might be a rare but reported risk associated with fluoroquinolones. What are the implications for your practice? Dr. David Johnson offers commentary.
  • Colorectal Cancer Screening: Guidelines for Best Practice   The American College of Physicians recently issued new colorectal cancer screening guidelines. Dr. David Johnson offers his perspective on the key recommendations and the impact on clinical practice.
  • PPIs and C difficile: Putting the Risk in Perspective   The FDA is warning that PPIs may be associated with a higher risk for C difficile-associated diarrhea. What does this mean for your patients? Dr. David Johnson offers his guidance to clinicians.
  • Interval Colon Cancers: Is Biology to Blame or Are We?   The risk for interval colon cancers is low, but they do occur. Is this due to biology or colonoscopy technique? Dr. David Johnson comments, focusing on a number of recent studies.
  • Celiac Disease: What Is Your Biopsy Protocol?   Dr. David Johnson comments on an analysis of biopsy protocols in the evaluation of celiac sprue that suggests a low adherence to the current guideline recommendations. Are diagnoses being missed?
  • From the Upper GI to the Lower GI: A Recap of ACG 2011   Dr. David Johnson offers his perspective on some of the key scientific presentations from this year's American College of Gastroenterology meeting.
  • Barrett Esophagus: Are We Screening Too Often?   With recent studies showing the progression of Barrett esophagus to esophageal cancer to be lower than originally thought, is routine screening still needed? Dr. David Johnson offers commentary.
  • Increasing Adenoma Detection in the Right Colon   Could right-sided colonoscope retroflexion improve adenoma detection? Dr. David Johnson explores a recent report that demonstrates the value of this easily learned technique.
  • Proton Pump Inhibitors and Bone Fractures: What's the Risk?   Dr. David Johnson offers his perspective on a recent systematic review and meta-analysis that evaluated the potential risk for bone fractures associated with proton pump inhibitor use.
  • Rethinking Surveillance of Barrett Esophagus   Dr. David Johnson comments on the practice of routine endoscopic surveillance after a study reports that the risk of Barrett esophagus progressing to esophageal cancer is lower than previously thought.